SANA

Sana Biotechnology Inc

NASDAQ: SANA · HEALTHCARE · BIOTECHNOLOGY

$3.56

-9.46% today

Updated 2026-06-05

Market cap

$745.82M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.92

Dividend yield

—

52W range

$3 – $7

Volume

3.8M

Market cap

$745.82M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.92

Dividend yield

—

52W range

$3 – $7

Volume

3.8M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

3.5

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-7.1

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →199 stocks currently score above 75

Price targets

Analyst target

$8.57

+140.73%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy6 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -7.14 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-37.67M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-266.39M	$-283.25M	$-266.76M	$-244.17M	$-47.21M
EPS	—	—	—	—	$-0.92
Free cash flow	$-310.93M	$-273.61M	$-256.58M	$-144.77M	$-37.67M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-06-04	YANG, PATRICK Y	Buy	90,000	—
2026-06-04	SEITZ, MICHELLE	Buy	90,000	—
2026-06-04	ROSIELLO, ROBERT L.	Buy	90,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SANA	$745.82M	23	4.3	3.0	5.0	3.5	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Sana Biotechnology Inc trades at $3.56. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -7.14, it sits in the distress.

Frequently asked questions

What is Sana Biotechnology Inc's stock price?

Sana Biotechnology Inc (SANA) trades at $3.56.

Is Sana Biotechnology Inc overvalued?

Sana Biotechnology Inc carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Sana Biotechnology Inc (SANA)?

The 12-month analyst consensus target is $8.57, about 140.7% above the current $3.56. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Sana Biotechnology Inc's Altman Z-Score is -7.14, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-202.94%

Beta2.16

50D MA$3.22

200D MA$3.84

Shares out0.28B

Float0.18B

Short ratio—

Avg volume3.8M

Performance

1 week+0.00%

1 month-12.70%

3 months-20.24%

YTD-34.15%

1 year—

3 years—

5 years—

Compare

SANA vs LLY →SANA vs JNJ →SANA vs ABBV →Stock screener →